+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial



Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial



British Journal of Psychiatry 160: 519-524



The effects of moclobemide (300-600 mg/day), a reversible monoamine oxidase inhibitor - A (MAOI-A), were compared in a double-blind, multi-centre trial with those of clomipramine (100-200 mg/day) on 129 in-patients suffering from endogenous depression (according to ICD-9 and the Newcastle Scale). No significant differences in efficacy were seen between the two treatment groups. In the moclobemide group the mean scores on the MADRS were 36.4 on day 0 and 13.2 on day 42 (end-point analysis); scores were 37.4 and 10.9 respectively in the clomipramine group. An earlier onset of antidepressant activity was noted for moclobemide. Tolerability was significantly better for moclobemide, as shown by the Clinical Global Impression of Tolerance (CGIT). Anticholinergic effects, weight gain and orthostatic hypotension were more frequent in the clomipramine group. No biological treatment-related changes were observed.

(PDF emailed within 1 workday: $29.90)

Accession: 040711162

Download citation: RISBibTeXText

PMID: 1571752


Related references

Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 50-51, 1990

Moclobemide and clomipramine in endogenous depression. A randomized clinical trial. Acta Psychiatrica Scandinavica 79(6): 523-529, 1989

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. Journal of Affective Disorders 76(1-3): 191-200, 2003

Multicenter double-blind randomized parallel-group clinical trial of effectiveness of the combination clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar major depression. European Neuropsychopharmacology 10(Suppl. 3): S249, 2000

Moclobemide Versus Clomipramine in Endogenous Depression. British Journal of Psychiatry 160(4): 519-524, 1992

Double-blind trial with oral versus intravenous clomipramine in primary depression. Biological Psychiatry 18(6): 695-706, 1983

Moclobemide ro 11 1163 vs. clomipramine in the treatment of depression a double blind multicenter study in belgium. Drug Development Research 21(4): 325-332, 1990

Moclobemide (Ro 11-1163) vs. clomipramine in the treatment of depression: A double-blind multicenter study in Belgium. Drug Development Research 21(4): 325-331, 1990

A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 41s-45s, 1995

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatrica Scandinavica 104(2): 104-109, 2001

Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain. Acta Psychiatrica Scandinavica. Supplementum 360: 48-49, 1990

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry 42(1): 22-29, 2002

Paroxetine versus clomipramine in adolescents with severe major depression: A double-blind, randomized, multicenter trial. Journal of the American Academy of Child & Adolescent Psychiatry 42(1): 22-29, 2003

Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 24s-30s, 1995

Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. Acta Psychiatrica Scandinavica 70(3): 254-260, 1984